SEARCH  web site
COMPANIES
Discover the reality of companies and brands !
List by name, country, industry, manager, or updated this month, by topic:
WHO ARE WE? - HELP - BOOKSTORE
CONTACT T&C BY EMAIL OR WITH SKYPE Skype Me™!
SHOP LOCAL, ETHICAL AND AT THE BEST PRICE WITH Ethishop
 
 en español  en français  in italiano
translate in arabic chinese dutch german japanese korean russian

Home (12954 companies) > France (2162 companies) > Pharmaceuticals (35 companies) >



Sanofi-Aventis


Headquarters location: 174 avenue de France 75635 Paris Cedex 13FranceTel. 33-1-53-77-44-45 Job offers, investor relations: www.sanofi-aventis.com Email: investor-relations@sanofi-synthelabo.com


Sanofi Aventis belongs to

shareholder
country     %
source
EmployésWorld1
KPC CorpKuwait6.19
L'OréalFrance10.41
Sanofi-AventisFrance4.4AFP
State Street Corp.United States of America5Boursier.c.
Total SAFrance12.99

Sanofi Aventis owns

subsidiary
country     %
source
Aventis SA France100
Genfit France Les Echos
Hoechst AG Germany100Cercle Fin.
Sanofi France100
Sanofi-Aventis France4.4AFP
Zentiva Netherlands25Financial .

Brands

name
items photo compare the prices
AllegraSee the photo of: AllegraEthishop
AprovelSee the photo of: AprovelEthishop
Astra-SynthélaboSee the photo of: Astra-SynthélaboEthishop
Chinoin RtSee the photo of: Chinoin RtEthishop
CopaxoneSee the photo of: CopaxoneEthishop
EloxatineSee the photo of: EloxatineEthishop
IrexSee the photo of: IrexEthishop
LactacydSee the photo of: LactacydEthishop
LantusSee the photo of: LantusEthishop
LipofactorSee the photo of: LipofactorEthishop
LovenoxSee the photo of: LovenoxEthishop
MitosylSee the photo of: MitosylEthishop
PlavixSee the photo of: PlavixEthishop
Sanofi-Aventis See the photo of: Sanofi-AventisEthishop
Sanofi-Synthelabo See the photo of: Sanofi-SynthelaboEthishop
StilnoxSee the photo of: StilnoxEthishop
TaxotereSee the photo of: TaxotereEthishop
TritaceSee the photo of: TritaceEthishop
Shop local, ethical and at the best price on Ethishop !

« ETHICAL » RATING OF SANOFI_AVENTIS , group and subsidiaries [?]
4%
Job: 4% of company's jobs cut since 1998
4
Environment: 4 major pollution(s)
12
Delinquency: 12 act(s) of financial or trade delinquency
3
Tax haven, secret bank account, shell companies: operates in 3 offshore financial center(s)
25
Sales: more than 25 billion(s) dollars/euros in annual sales
4
Net profit: more than 4 billion(s) dollars/euros in cumulated net profit since 1998
806
Top management: earns 806 times the median income in the United States (32000 US$/year)
10
Influence: 10 act(s) of direct corruption or lobbying
3
Advertising & marketing: 3 dubious practice(s)

Relevance: business & market share

year
business
source
2007Sanofi-Aventis SA, France's largest drugmaker
2007Sanofi-Aventis is France's largest drugmaker.
2006Sanofi-Aventis is the world's fourth-largest pharmaceutical group.Les Echos
2006Sanofi-Aventis sells 23% of the vaccines bought in the world.Les Echos
2004The world's third-largest pharmaceutical company with 70 plants in the world, 19 of which in France.

World locations & Manufacturing

country incentive : address & contact : production type
source
United States of America  Great Valley, Pennsylvanie : R&D Les Echos
France  Montpellier : R&D Les Echos
France  Toulouse : R&D Les Echos
France  Chilly-Mazarin : R&D Les Echos
France  Bagneux : R&D Les Echos
France  Porcheville : R&D Les Echos
Hungary  Chinoin Rt : Les Echos
United Kingdom  Alnwick : R&D Les Echos

Sanofi Aventis is managed by

year name
photo position; compensation
source
2004Laimay, Marie-Hélène
See the photo of: Laimay, Marie-Hélène Chief Financial Officer;
2002Dehecq, Jean-François
See the photo of: Dehecq, Jean-François Chief Executive Officer; salary: 1.9 million Eu€; stock-options: 6 million Eu€;
2001Dehecq, Jean-François
See the photo of: Dehecq, Jean-François Chief Executive Officer; salary: 4 million Eu€;
1999Barbier de la Serre, René
See the photo of: Barbier de la Serre, René Director;
1999Castaigne, Robert
See the photo of: Castaigne, Robert Director;
1999De Gennes, Pierre-Gilles
See the photo of: De Gennes, Pierre-Gilles Director;
1999Desmarest, Thierry
See the photo of: Desmarest, Thierry Director;
1999Martin, Pierre Castres Saint
See the photo of: Martin, Pierre Castres Saint Director;
1999Owen-Jones, Lindsay
See the photo of: Owen-Jones, Lindsay Director;
1999Weymuller, Bruno
See the photo of: Weymuller, Bruno Director;
1998Guérin, Hervé
See the photo of: Guérin, Hervé Chief Executive Officer;

Advertising & marketing

year
dubious practice : image
source
2005Arguable partnership: S'est allié à la fondation Drugs for Neglected Diseases Initiative pour la mise au point et la distribution d'ici 2006 d'un traitement à prix coûtant contre le paludisme. Le paludisme est une maladie délaissée par les centres de recherche des grands laboratoires privés. « On n'arrive pas à trouver une rentabilité, qui est à la base de nos projets de recherche, tout le monde le comprendra », explique Philippe Baetz, vice-président de Sanofi-Aventis.: value: Health; Libération
2004slogan: Nous refusons l'idée de ne pas développer les médicaments de demain pour un simple problème de taille;
1999slogan: L'essentiel, c'est la santé;

Made by

year
employees
<>
social impact : country
source
2008
100000
-380
Internal restructuring: Sanofi-Aventis cuts 380 jobs of medical representatives in Germany.: Germany
L'Expansio.
2007
-40
Internal restructuring: Canada
Les Echos
2007
-118
Internal restructuring: Sanofi-Aventis restructures its Neuville-on-Saone factory because of the fall of the sales of the Ketek drug.: France
Les Echos
2005
-504
Merger/Acquisition: Suite à la fusion Aventis-Sanofi, 500 salariés de plus de 55 ans ont accepté une cessation anticipée, avec 70% du salaire net.: France
Les Echos
2004
-330
Internal restructuring:
La Vie Fin.
2004
99700
2002
32436
2001
30514
2000
29200

Environmental impact

year
country : consequences
source
2006France : The International Chamber of Commerce of Paris confirmed the "environmental responsibility" of Sanofi for the underground pollution with mercury of the Vieux-Thann site.Les Echos

Influence

year
purpose : intermediary/lobby : institution
source
2000Limit the legal liability, no price control, no list of preferred drugs, hampers the approval and marketing of generic drugs, no drug imports, no limit to drug advertising… : Pharmaceutical Research and Manufacturers of America : : US government, congress, senate translateWashington.
2000lift the ban on bovine growth hormon : FEDESA : : European Commission translateFedesa
2000Lift the ban on bovine growth hormons, the moratorium on GMOs : EFPIA (European Federation of Pharmaceutical Industry Associations) : : European Commission translateEFPIA

Financials

yearfinancial misdemeanorsalesincome buybacksource
2007   28.056.96   billion Eu€
2007 Sanofi pays US$190 million to the US Department of Justice to settle allegations of fraud in the pricing and marketing of a drug used for cancer treatment side effects. From September 1997 to June 2004, Sanofi's subsidiary Aventis allegedly artificially inflate the price of the drug Anzemet, increasing the cost of government reimbursements for the drug.     AP
2006   27.756.57   billion Eu€
2004   1.53billion Eu€Boursier.c.
2004   25   billion US$
2003   8.721.1   billion Eu€
2003   1billion Eu€AFP
2003   0.14billion Eu€Boursier.c.
2002   7.451.58   billion Eu€
2001   6.490.98   billion Eu€
2000   5.960.62   billion Eu€
1999   5.35   billion Eu€

Home > Companies: # A B C D E F G H I J K L M N O P Q R S T U V W X Y Z >


Further investigation
Good corporate practice? Pollution, layoff plan? Doubtful publicity or lobbying? Take part! Publish here :
Also announce a documentary, a book or an article or comment this company profile.
Goal
: present the company activities, improve the ethical rating's accuracy, develop an network of observers.
Name (or ninckname)*
Email
Title*
Link to document online
Information*
Alert me of answers by email * required field
Please copy the antispam code:


The 5 latest validated comments

Subscribe - Log in - Log out |
| © T&C 1999-2008